Novamind to Present at the Planet MicroCap Virtual Event on April 22, 2021

Rhea-AI Summary

Novamind Inc. will present at the SNN Planet MicroCap Showcase on April 22, 2021, at 10:00 AM EST. CEO Yaron Conforti will discuss the company's vision for expanding access to psychedelic medicine, including its recent milestones and clinical infrastructure. Additionally, Novamind will participate in a panel titled "Past, Present and Future of Psychedelics" on April 20, 2021, at 7:00 PM EST. Investors can tune in to the events via the provided links for webcast and one-on-one meetings.

TORONTO, ON / ACCESSWIRE / April 19, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will present at the SNN Planet MicroCap Showcase on Thursday, April 22^nd at 10:00 AM EST.

Yaron Conforti, Novamind's CEO, will present at the event, outlining Novamind's vision for scaling access to psychedelic medicine and taking questions from investors. The presentation will cover Novamind's clinical and research infrastructure, recent milestones, and its expansion plans for 2021.

Novamind will also be featured on a panel discussion titled, "Past, Present and Future of Psychedelics" on Tuesday, April 20^th at 7:00 PM EST.

Presentation information:

To tune in to the webcast, please visit this link.

To book a one-on-one investor meeting with Novamind or to watch the Company's presentation, please register for the virtual event here. One-on-one meetings will be scheduled and conducted via private, secure video conference through the conference event platform.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.

Contact Information

Novamind
Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512

Bill Mitoulas, Investor Relations
Email: bill@novamind.ca

SOURCE: Novamind Inc.

View source version on accesswire.com:
https://www.accesswire.com/641074/Novamind-to-Present-at-the-Planet-MicroCap-Virtual-Event-on-April-22-2021

FAQ

When is Novamind's presentation at the SNN Planet MicroCap Showcase?

Novamind's presentation is scheduled for April 22, 2021, at 10:00 AM EST.

Who will present for Novamind at the event?

CEO Yaron Conforti will present for Novamind.

What will be discussed in Novamind's presentation?

The presentation will cover Novamind's vision for expanding access to psychedelic medicine, recent milestones, and clinical infrastructure.

Is Novamind participating in any panel discussions?

Yes, Novamind will be featured in a panel discussion on the "Past, Present and Future of Psychedelics" on April 20, 2021, at 7:00 PM EST.

How can investors register for Novamind's virtual event?

Investors can register for the virtual event through the links provided in the press release.

What is the stock symbol for Novamind?

Novamind's stock symbol is NVMDF.